Följ
Tomonori Tanei
Tomonori Tanei
大阪大学医学部乳腺内分泌外科
Verifierad e-postadress på onsurg.med.osaka-u.ac.jp
Titel
Citeras av
Citeras av
År
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast …
T Tanei, K Morimoto, K Shimazu, SJ Kim, Y Tanji, T Taguchi, Y Tamaki, ...
Clinical cancer research 15 (12), 4234-4241, 2009
6952009
Stem cell marker aldehyde dehydrogenase 1‐positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and …
K Morimoto, SJ Kim, T Tanei, K Shimazu, Y Tanji, T Taguchi, Y Tamaki, ...
Cancer science 100 (6), 1062-1068, 2009
3162009
Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
T Tanei, A Shimomura, K Shimazu, T Nakayama, SJ Kim, T Iwamoto, ...
European Journal of Surgical Oncology (EJSO) 37 (2), 155-161, 2011
1092011
Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment
K Yokoi, M Kojic, M Milosevic, T Tanei, M Ferrari, A Ziemys
Cancer research 74 (16), 4239-4246, 2014
922014
Emerging technologies for real‐time intraoperative margin assessment in future breast‐conserving surgery
AR Pradipta, T Tanei, K Morimoto, K Shimazu, S Noguchi, K Tanaka
Advanced Science 7 (9), 1901519, 2020
802020
Correlation of methylated circulating tumor DNA with response to neoadjuvant chemotherapy in breast cancer patients
H Takahashi, N Kagara, T Tanei, Y Naoi, M Shimoda, A Shimomura, ...
Clinical breast cancer 17 (1), 61-69. e3, 2017
742017
Redirecting transport of nanoparticle albumin-bound paclitaxel to macrophages enhances therapeutic efficacy against liver metastases
T Tanei, F Leonard, X Liu, JF Alexander, Y Saito, M Ferrari, B Godin, ...
Cancer research 76 (2), 429-439, 2016
652016
Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments
K Yokoi, T Tanei, B Godin, AL van de Ven, M Hanibuchi, A Matsunoki, ...
Cancer Letters 345 (1), 48-55, 2014
652014
Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
T Tanei, DS Choi, AA Rodriguez, DH Liang, L Dobrolecki, M Ghosh, ...
Breast Cancer Research 18, 1-9, 2016
602016
Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients
Y Naoi, K Kishi, T Tanei, R Tsunashima, N Tominaga, Y Baba, SJ Kim, ...
Breast cancer research and treatment 128, 633-641, 2011
572011
Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer
Y Tabuchi, M Shimoda, N Kagara, Y Naoi, T Tanei, A Shimomura, ...
Breast cancer research and treatment 157, 55-63, 2016
542016
Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions
F Leonard, LT Curtis, P Yesantharao, T Tanei, JF Alexander, M Wu, ...
Nanoscale 8 (25), 12544-12552, 2016
542016
Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing
C Mishima, N Kagara, T Tanei, Y Naoi, M Shimoda, A Shimomura, ...
Breast cancer research and treatment 152, 305-312, 2015
512015
PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
AM Ohara, Y Naoi, K Shimazu, N Kagara, M Shimoda, T Tanei, T Miyake, ...
Breast cancer research and treatment 173, 533-543, 2019
422019
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer
A Hori, M Shimoda, Y Naoi, N Kagara, T Tanei, T Miyake, K Shimazu, ...
Breast Cancer Research 21, 1-18, 2019
402019
Cascade reaction in human live tissue allows clinically applicable diagnosis of breast cancer morphology
T Tanei, AR Pradipta, K Morimoto, M Fujii, M Arata, A Ito, M Yoshida, ...
Advanced Science 6 (2), 1801479, 2019
372019
Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing
T Yanagawa, N Kagara, T Miyake, T Tanei, Y Naoi, M Shimoda, ...
Breast cancer research and treatment 163, 231-240, 2017
372017
Prediction of pathologic complete response to sequential paclitaxel and 5‐fluorouracil/epirubicin/cyclophosphamide therapy using a 70‐gene classifier for breast cancers
Y Naoi, K Kishi, T Tanei, R Tsunashima, N Tominaga, Y Baba, SJ Kim, ...
Cancer 117 (16), 3682-3690, 2011
362011
Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier
K Yokoi, D Chan, M Kojic, M Milosevic, D Engler, R Matsunami, T Tanei, ...
Journal of Controlled Release 217, 293-299, 2015
352015
A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells
Y Chihara, M Shimoda, A Hori, A Ohara, Y Naoi, J Ikeda, N Kagara, ...
Breast cancer research and treatment 166, 55-68, 2017
332017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20